Contact this trialFirst, we need to learn more about you.
Antiretroviral
DOR/ISL for HIV/AIDS
Recruiting2 awardsPhase 3
Savannah, Georgia
This trial will test the safety and effectiveness of a new drug combination in people with HIV who have the virus under control with current treatment. The new combination includes doravirine and islatravir. The goal is to see if the new treatment is at least as good as the current one in controlling the virus.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.